Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Inflation Showing Signs of Easing
Greg McBride, chief financial analyst at Bankrate.com, joined Cheddar News to discuss inflation trends. “I think with strong confidence that peak inflation is behind us, the trend is definitely one towards continued improvement but we've got a long way to go,” he said.
The Future of the Non-Alcoholic Beverage Industry
Nick Bodkins, CEO & founder of beverage collection Boisson, joined Cheddar News to discuss how the industry of non-alcoholic is gaining popularity. “This category is growing but it doesn't have that scale yet.”
Load More